Skip to main content
  • Policy
    Get Involved
    Watch Best of BIO
    Advocacy Toolkit
    BIOAction
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    Agriculture & Environment
    Food and Farm Innovation
    Sustainable Fuels
    Biobased Manufacturing
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Join Today
    Member Directory
    Have a Voice
    Membership Eligibility
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member ag&evnt
    Agriculture & Environment
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    BIO Business Solutions
    Join Today
  • News & Insights
    Latest blogs on BIOtechNOW
    Watch Best of BIO
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    Good Day BIO
    I AM BIO Podcast
    All News & Insights

    Sign up for the Good Day BIO Newsletter >

  • BIOEquality
    1. Promote

    Health equality in access to medicines and ensuring diversity in clinical trials.

    2. Invest

    In the current and next generation of black scientists and entrepreneurs.

    3. Expand

    Opportunities for women, Black and other minority populations in the growing Bio-economy.

    The Right Mix Matters

    Providing tools to accelerate gender, racial, ethnic and LGBTQ representation on biotech company boards, in C-suites and in functional leadership positions.

  • Events
    Event Portfolio
    Business Development
    Health
    Agriculture & Environment
    International
    Members Only
    All Events
    BIO Digital 2021

    June 10-11 & 14-18, 2021

    New extended dates for the world’s largest biotech partnering experience

    Register Now!
    Evt Bif MegaMenu
    BIO Investor Forum Digital

    October 19-20, 2021
    Watch the Best of BIO Sessions

    BIO Partnering @ JPM
    BIO Patient & Health Advocacy Digital Summit

    October 27-28, 2021

    Evt CEO MegaMenu
    BIO CEO & Investor Digital Conference

    Watch the Best Sessions Now >

    BIO Online Learning

    BIO now offers on-demand online classes that can be taken anywhere, anytime and at your own pace. BIO Member and group discounts available!

  • About
    About Us
    Learn about our mission, vision, values and priorities
    Programs & Initiatives
    Find out about BIO's programs & initiatives
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • BIO Media
    BIO Media

    Bringing you daily news at the intersection of biotechnology, politics, patients & the planet.

    I am BIO Podcast
    Good Day BIO Newsletter
    I am BIO Video
    Join Today
  • Search
Logo
Logo
Home
Search
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
Logo
Logo
Search
Explore the Blog
  • Human Health
  • Agriculture & Environment
  • Business & Bio Industry
  • Policy & Regulatory
  • International Issues
  • Network & Partnering
  • Events
1004 Results Found

Blog_BIOPartnering
New BIO One-on-One Partnering Mobile App
BIO has released a new and improved mobile app for the BIO One-on-One Partnering™ system. After intensive surveys and interviews with attendees who have engaged in partnering at BIO business development & investor events around the world, we revamped our partnering mobile app to make the…

BIO Logo
BIO's Leadership Transition | "The fight continues..."
On Tuesday, October 8, BIO formally announced that its President and CEO Jim Greenwood would be stepping down from the world's largest biotechnology organization in January 2021. In a letter to BIO staff, Greenwood reflected on his rise to BIO and the accomplishments the organization has achieved…

Gavel sitting on top of a book that reads PATENT LAW
#TBT: Debunking Some Common Myths on Patent Protections
The Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce is set to examine the U.S. patent system this morning. Ahead of the hearing – and in honor of #ThrowBackThursay – we are resurfacing a piece by BIO’s Tom DiLenge that helps debunk some of the most…

Triple Crown
Pitch Perfect – Storytelling is Key for BIO One-on-One Partnering
Keith Ignotz knows the power of a good story. The President & CEO of OcuMedic—an early stage biotech company developing a novel pre-and post-eye surgery treatment to replace eye drops—has made significant inroads telling the OcuMedic story since he assumed his role in early 2018. Some of his…

BTN-MTC_Stock-Market-364x210
The Strong Keep Getting Stronger: Why the Bay Area Remains #1 Biotech Hub for VC Investing
Whether you come to the Bay Area for the entrepreneurial talent, venture capital investment or biotech innovation, this trifecta conjures the perfect storm for regional economic success. The enduring strength of the Northern California life science cluster attracts small biotech startups, which are…

BIO Investor Forum
The BIO Investor Forum Links Promising Early-Stage Technologies with an Active Investor Network
As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial dollars have followed suit.  According to BIO’s 2019 Emerging Therapeutic Company Trend Report, a record $17.5 billion in venture investment dollars went to emerging therapeutic companies globally in…

BIF
Influential investor, Wende Hutton, to Speak at #BIF19
In a few short months BIO will be hosting the BIO Investor Forum (#BIF19) for the 17th time. The event’s long history is testament to the continued appetite for partnerships, collaborations and investment in the exciting world of early stage biotech companies on the cusp of medical breakthroughs…

BIO World Congress
#BIOWC19 Day 3 Wrap-Up: Bringing People, Ideas, and Technology Together
Day three of the 2019 BIO World Congress began by awarding three individuals who have had a profound impact on industrial and agricultural biotechnology. It was a fitting moment because, just like them, #BIOWC19 is bringing people, ideas, and technology together to bolster the bio-economy and…

BTN-MTC_Patient-Pharmacy.png
How Can We Control Drug Costs While Supporting Innovation?
As the debate on drug pricing continues, our elected leaders will almost certainly adopt policies that will significantly impact—for better or for worse—the lives of many patients. With that in mind, how we do we ensure patients are at the center of this discussion? It starts by recognizing some…

BIO World Congress
#BIOWC19 Kicks Off: Biotech Breakthroughs Take Center Stage in Des Moines
Tomorrow, biotech breakthroughs—such as biofuels that reduce carbon pollution, biodegradable plastics made from plants, or gene-edited crops that can withstand and mitigate the effects of climate change—will take center stage in Des Moines for the 2019 BIO World Congress on Industrial Biotechnology…

Pagination

  • « « First
  • ‹ ‹‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • › ››
  • » Last »
Explore BIO
Policy
Events
Industry Insights
About
Join Now
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Digital
BIO CEO & Investor Conference
BIO Investor Forum Digital
BIO IMPACT Digital
BIO Online Learning
BIO DOUBLE HELIX SPONSORS
Amgen
Bristol Myers Squibb
Johnson & Johnson Logo
Merck
Avantor
BIO HELIX SPONSORS
Eli Lilly and Company
Genentech Logo
Samsung Biologics
Twist Biopharma Logo
1201 Maryland Avenue SW, Suite 900, Washington, DC, 20024 ・ 202-962-9200
© BIO 2021 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO